{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:22:39Z","timestamp":1791969759647,"version":"4.3.4"},"reference-count":61,"publisher":"American Society of Hematology","issue":"21","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Management of recurrent gastrointestinal (GI) bleeding is a clinical unmet need for patients with von Willebrand disease (VWD) and is linked to the presence of gut vascular malformations (angiodysplasia). We previously demonstrated that von Willebrand factor (VWF) regulates angiogenesis and vascular integrity. VWF controls the storage of the angiogenesis regulator angiopoietin-2 (Angpt-2) in endothelial cells (EC), suggesting a candidate for the genesis of angiodysplasia; however, no direct evidence of the role of Angpt-2 in VWF-dependent angiogenesis is available. Using VWF-deficient human umbilical vein EC (HUVEC) and endothelial colony-forming cells (ECFCs) from patients with severe VWD, we found that loss of VWF resulted in increased Angpt-2 expression through the positive feedback loop Angpt-2\u2013Tie-2\u2013Akt\u2013FOXO1\u2013Angpt-2. In the gut of VWF-deficient mice, Angpt-2 expression was increased, whereas Angpt-1 expression was decreased, suggesting that VWF regulates the Angpt\/Tie2 balance in the gut. Moreover, the intestinal vasculature in the jejunum of VWF-deficient mice appeared abnormal, with hypersprouting and lumen formation defects. The findings reveal VWF-deficient mice as a model to study gut angiodysplasia. We investigated sprouting angiogenesis in vitro using a fibrin bead assay and found increased sprouting in VWF-deficient EC. We developed a 3-dimensional microfluidic model of angiogenesis and found that ECFCs from patients with severe VWD exhibit defective remodeling and abnormal lumen formation, reminiscent of the defects in the gut of VWF-deficient mice. Importantly, inhibition of Angpt-2 reduced sprouting in VWF-deficient HUVEC and normalized vascular remodeling in VWD-ECFCs, suggesting that Angpt-2 inhibitors may be effective in patients with VWD with GI bleeding and angiodysplasia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031558","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:54:52Z","timestamp":1769446492000},"page":"2541-2553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Von Willebrand factor deficiency impairs angiogenesis via angiopoietin-2: relevance for gut angiodysplasia"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1274-2867","authenticated-orcid":false,"given":"Adela","family":"Constantinescu-Bercu","sequence":"first","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koval E.","family":"Smith","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0683-7681","authenticated-orcid":false,"given":"Shuo Yi","family":"Wong","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1934-9644","authenticated-orcid":false,"given":"Mattia","family":"Ballerini","sequence":"additional","affiliation":[{"name":"2Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Nastro","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"},{"name":"2Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-2004","authenticated-orcid":false,"given":"Benjamin G.","family":"Wiggins","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-4176","authenticated-orcid":false,"given":"Daniela","family":"Pirri","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Li","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juun","family":"Evers","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-3746","authenticated-orcid":false,"given":"Olga","family":"Tsiamita","sequence":"additional","affiliation":[{"name":"3The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-8628","authenticated-orcid":false,"given":"Matthew","family":"Dibble","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Pericleous","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-6140","authenticated-orcid":false,"given":"Koralia","family":"Paschalaki","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-8672","authenticated-orcid":false,"given":"Graeme M.","family":"Birdsey","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-1049","authenticated-orcid":false,"given":"Jeremiah","family":"Bernier-Latmani","sequence":"additional","affiliation":[{"name":"4Department of Fundamental Oncology, University of Lausanne and Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Petrova","sequence":"additional","affiliation":[{"name":"4Department of Fundamental Oncology, University of Lausanne and Ludwig Institute for Cancer Research Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3268","authenticated-orcid":false,"given":"Michael A.","family":"Laffan","sequence":"additional","affiliation":[{"name":"5Centre for Haematology, Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthesh","family":"Sivapalaratnam","sequence":"additional","affiliation":[{"name":"3The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"},{"name":"6Precision Healthcare University Research Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-8652","authenticated-orcid":false,"given":"Marco","family":"Rasponi","sequence":"additional","affiliation":[{"name":"2Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-211X","authenticated-orcid":false,"given":"Anna M.","family":"Randi","sequence":"additional","affiliation":[{"name":"1National Heart and Lung Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2026052111215239100_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"2026052111215239100_bib2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2026052111215239100_bib3","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2026052111215239100_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1160\/TH13-11-0952","article-title":"Gastrointestinal angiodysplasia and bleeding in von Willebrand disease","volume":"112","author":"Franchini","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"2026052111215239100_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12571","article-title":"The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease","volume":"21","author":"Makris","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"2026052111215239100_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","article-title":"von Willebrand factor regulation of blood vessel formation","volume":"132","author":"Randi","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026052111215239100_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/hae.15034","article-title":"Retrospective chart review of GI bleeding in people with von Willebrand disease","volume":"30","author":"Roberts","year":"2024","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"2026052111215239100_bib8","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.thromres.2006.01.022","article-title":"Gastrointestinal bleeding in von Willebrand disease","volume":"118","author":"Makris","year":"2006","journal-title":"Thromb Res"},{"issue":"3","key":"2026052111215239100_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0038-1649623","article-title":"International survey of patients with von Willebrand disease and angiodysplasia","volume":"70","author":"Fressinaud","year":"1993","journal-title":"Thromb Haemost"},{"issue":"12","key":"2026052111215239100_bib10","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2004.40459.x","article-title":"Gastrointestinal angiodysplasia in a patient with type 2 von Willebrand's disease and analysis of exon 28 of the von Willebrand factor gene","volume":"99","author":"Satoh","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2026052111215239100_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand disease prophylaxis network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"issue":"8","key":"2026052111215239100_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/17474086.2023.2221846","article-title":"Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations","volume":"16","author":"Ocran","year":"2023","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"2026052111215239100_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2026052111215239100_bib14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.119.313021","article-title":"Weibel-Palade bodies orchestrate pericytes during angiogenesis","volume":"39","author":"Cossutta","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"2026052111215239100_bib15","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.2019000510","article-title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","volume":"133","author":"Ishihara","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2026052111215239100_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2015-10-677054","article-title":"von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells","volume":"128","author":"Lopes da Silva","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2026052111215239100_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"issue":"Pt 1","key":"2026052111215239100_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1242\/jcs.03494","article-title":"Formation and function of Weibel-Palade bodies","volume":"121","author":"Metcalf","year":"2008","journal-title":"J Cell Sci"},{"issue":"11","key":"2026052111215239100_bib19","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2026052111215239100_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"2026052111215239100_bib21","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026052111215239100_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","article-title":"Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation","volume":"1347","author":"Scholz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"14","key":"2026052111215239100_bib23","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2026052111215239100_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCRESAHA.115.303227","article-title":"FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis","volume":"115","author":"Dharaneeswaran","year":"2014","journal-title":"Circ Res"},{"issue":"9","key":"2026052111215239100_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/nprot.2016.092","article-title":"High-resolution 3D analysis of mouse small-intestinal stroma","volume":"11","author":"Bernier-Latmani","year":"2016","journal-title":"Nat Protoc"},{"issue":"3","key":"2026052111215239100_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10456-018-9613-x","article-title":"Consensus guidelines for the use and interpretation of angiogenesis assays","volume":"21","author":"Nowak-Sliwinska","year":"2018","journal-title":"Angiogenesis"},{"issue":"3","key":"2026052111215239100_bib27","first-page":"186","article-title":"Optimized fibrin gel bead assay for the study of angiogenesis","author":"Nakatsu","year":"2007","journal-title":"J Vis Exp"},{"issue":"1","key":"2026052111215239100_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/1535-7163.MCT-09-0554","article-title":"A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models","volume":"9","author":"Brown","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2026052111215239100_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41551-024-01318-z","article-title":"A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma","volume":"9","author":"Ballerini","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"2026052111215239100_bib30","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood-2007-08-105346","article-title":"Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin","volume":"111","author":"Birdsey","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2026052111215239100_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","article-title":"Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium","volume":"29","author":"Yuan","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"5322","key":"2026052111215239100_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"7","key":"2026052111215239100_bib33","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/MCB.18.7.4131","article-title":"Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt","volume":"18","author":"Kontos","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2026052111215239100_bib34","doi-asserted-by":"crossref","first-page":"ar21","DOI":"10.1091\/mbc.E22-05-0193","article-title":"FOXO nuclear shuttling dynamics are stimulus-dependent and correspond with cell fate","volume":"34","author":"Lasick","year":"2023","journal-title":"Mol Biol Cell"},{"issue":"9","key":"2026052111215239100_bib35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.1189704","article-title":"Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)","volume":"18","author":"Daly","year":"2004","journal-title":"Genes Dev"},{"issue":"9","key":"2026052111215239100_bib36","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1172\/JCI23126","article-title":"Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization","volume":"115","author":"Potente","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"2026052111215239100_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0026-2862(03)00045-1","article-title":"Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1","volume":"66","author":"Nakatsu","year":"2003","journal-title":"Microvasc Res"},{"issue":"1","key":"2026052111215239100_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1160\/TH06-05-0277","article-title":"Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression","volume":"97","author":"Feng","year":"2007","journal-title":"Thromb Haemost"},{"issue":"4","key":"2026052111215239100_bib39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"2026052111215239100_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10456-024-09957-1","article-title":"Inhibition of angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss","volume":"28","author":"Tu","year":"2024","journal-title":"Angiogenesis"},{"key":"2026052111215239100_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fmed.2018.00295","article-title":"Recent advances in endothelial colony forming cells toward their use in clinical translation","volume":"5","author":"Paschalaki","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"suppl 1","key":"2026052111215239100_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","article-title":"The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story","volume":"11","author":"Nightingale","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026052111215239100_bib43","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jth.15713","article-title":"Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program","volume":"20","author":"Christopherson","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"15","key":"2026052111215239100_bib44","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/bloodadvances.2020003397","article-title":"Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS","volume":"5","author":"Baronciani","year":"2021","journal-title":"Blood Adv"},{"key":"2026052111215239100_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-8722-5-65","article-title":"The unfolded von Willebrand factor response in bloodstream: the self-association perspective","volume":"5","author":"Yuan","year":"2012","journal-title":"J Hematol Oncol"},{"issue":"14","key":"2026052111215239100_bib46","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/blood-2018-10-876300","article-title":"The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","volume":"133","author":"Dong","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2026052111215239100_bib47","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/jth.15740","article-title":"von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells","volume":"20","author":"Bowman","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026052111215239100_bib48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MBC.0000000000000635","article-title":"Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients","volume":"28","author":"Selvam","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"2026052111215239100_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","article-title":"Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1","volume":"3","author":"Gale","year":"2002","journal-title":"Dev Cell"},{"issue":"1","key":"2026052111215239100_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nsb880","article-title":"Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering","volume":"10","author":"Davis","year":"2003","journal-title":"Nat Struct Biol"},{"issue":"5","key":"2026052111215239100_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncb1714","article-title":"Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1","volume":"10","author":"Fukuhara","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2026052111215239100_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ncb1715","article-title":"Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts","volume":"10","author":"Saharinen","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"10","key":"2026052111215239100_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MCG.0000000000000260","article-title":"Expression of angiogenic factors in patients with sporadic small bowel angiodysplasia","volume":"49","author":"Holleran","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"2026052111215239100_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1160\/TH17-06-0397","article-title":"Circulating angiogenic mediators in patients with moderate and severe von Willebrand disease: a multicentre cross-sectional study","volume":"118","author":"Groeneveld","year":"2018","journal-title":"Thromb Haemost"},{"issue":"31","key":"2026052111215239100_bib55","doi-asserted-by":"crossref","first-page":"23842","DOI":"10.1074\/jbc.M109.097543","article-title":"Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation","volume":"285","author":"Thomas","year":"2010","journal-title":"J Biol Chem"},{"issue":"12","key":"2026052111215239100_bib56","first-page":"3403","article-title":"Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"issue":"17","key":"2026052111215239100_bib57","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2026052111215239100_bib58","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1074\/jbc.M305146200","article-title":"Hypoxic regulation of angiopoietin-2 expression in endothelial cells","volume":"279","author":"Pichiule","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"2026052111215239100_bib59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10456-020-09730-0","article-title":"Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients","volume":"23","author":"Smadja","year":"2020","journal-title":"Angiogenesis"},{"issue":"1","key":"2026052111215239100_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-023-09901-9","article-title":"Circulating von Willebrand factor: a consistent biomarker predicting in-hospital mortality across different waves of the COVID-19 pandemic","volume":"27","author":"Smadja","year":"2024","journal-title":"Angiogenesis"},{"issue":"2","key":"2026052111215239100_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe2018629","article-title":"Covid-19, angiogenesis, and ARDS endotypes","volume":"383","author":"Hariri","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2541\/2521272\/blood_bld-2025-031558-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2541\/2521272\/blood_bld-2025-031558-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:22:04Z","timestamp":1779376924000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/21\/2541\/566241\/Von-Willebrand-factor-deficiency-impairs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":61,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,5,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031558","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,21]]},"published":{"date-parts":[[2026,5,21]]}}}